← Back to Investors

BioAdvance

Philadelphia region's biotech seed fund, focused on early-stage life sciences companies. Provides seed and early Series A funding to startups in the greater Philadelphia area, supporting the region's life sciences ecosystem.

Location
Philadelphia, USA
Founded
2002
AUM
$60M+
Investment Range
$250K - $3M
Focus
biotech-focused
Fund Stages
seed, series-a

Investment Thesis

BioAdvance provides seed funding to early-stage life sciences companies in the Philadelphia region, helping translate academic research into commercial ventures. They focus on therapeutics, diagnostics, and medical devices, bridging the gap between academic discoveries and institutional venture funding.

Team

Partners / Managing Directors (Health & Bio Focus)

  • Barbara Schilberg - President & CEO

Other Key Team Members

  • Investment team with regional life sciences expertise
  • Strong ties to Philadelphia academic medical centers

Focus Areas

  • Therapeutics
  • Diagnostics
  • Medical Devices
  • Life Science Tools
  • Regional Life Sciences
  • University Spinouts

Notable Exits

  • Multiple companies advancing to Series A and beyond
  • Regional portfolio supporting Philadelphia life sciences ecosystem

Sources